SpringWorks Therapeutics Inc. achieved full enrollment in its Section 2 trial evaluating nirogacestat By Investing.com
SpringWorks Therapeutics Inc. (SWTX) achieved full enrollment in its Section 2 trial evaluating nirogacestat SpringWorks Therapeutics, ...
Read more